27776910|t|The Outcomes Following Revision of Monoblock Metal on Metal Acetabular Components for Painful Micromotion in the Absence of Adverse Local Tissue Reaction to Metal
27776910|a|Revision hip arthroplasty for metal-on-metal arthroplasty (MOMA) in the presence of an adverse local tissue reaction (ALTR) has been associated with compromised outcomes. We hypothesized that revision of MOMA for painful micromotion of the cup, in the absence of ALTR, would have a more favorable outcome. We reviewed our database for Durom acetabular shell revision with minimum 24 months (24 months to 8 years) follow-up. Patients with a diagnosis of painful micromotion in the absence of pseudotumor was identified. At mid-term follow-up, 71 patients had undergone revision of a Durom MOMA. Twenty-seven of these (38%) were for painful micromotion (9 total hip arthroplasty, 18 hip resurfacing) of the cup alone. Following revision surgery, all patients reported resolution of the preoperative pain, as well as satisfactory outcome measures (mean scores: The Western Ontario and McMaster Universities Arthritis Index [WOMAC] 84.6, oxford hip score 84.7, Short Form Health Survey (SF-16) 51, University of California, Los Angeles (UCLA) 7.3). Radiologically, all cases demonstrated osseointegration of the revision shells; 1 case had zone-3 radiolucency that was nonprogressive. One patient had a dislocation treated by closed reduction at 10 weeks. Revision MOMA for painful micromotion of the shell in the absence of ALTR is not similar to revision for ALTR and is associated with predictable improvement in pain and quality of life.
27776910	4	12	Outcomes	T169	C1274040
27776910	13	22	Following	T079	C0332282
27776910	23	31	Revision	T079	C0439617
27776910	35	50	Monoblock Metal	T197	C0025552
27776910	54	59	Metal	T197	C0025552
27776910	60	81	Acetabular Components	T074	C0182473
27776910	86	93	Painful	T184	C0030193
27776910	94	105	Micromotion	T070	C0026597
27776910	113	120	Absence	T169	C0332197
27776910	124	153	Adverse Local Tissue Reaction	T046	C3854631
27776910	157	162	Metal	T197	C0025552
27776910	163	171	Revision	T079	C0439617
27776910	172	188	hip arthroplasty	T061	C0186193
27776910	193	220	metal-on-metal arthroplasty	T061	C0003893
27776910	222	226	MOMA	T061	C0003893
27776910	235	243	presence	T033	C0150312
27776910	250	279	adverse local tissue reaction	T046	C3854631
27776910	281	285	ALTR	T046	C3854631
27776910	296	311	associated with	T080	C0332281
27776910	324	332	outcomes	T169	C1274040
27776910	337	349	hypothesized	T078	C1512571
27776910	355	363	revision	T079	C0439617
27776910	367	371	MOMA	T061	C0003893
27776910	376	383	painful	T184	C0030193
27776910	384	395	micromotion	T070	C0026597
27776910	403	406	cup	T074	C0180231
27776910	415	422	absence	T169	C0332197
27776910	426	430	ALTR	T046	C3854631
27776910	450	467	favorable outcome	T033	C1333602
27776910	472	480	reviewed	T080	C1709940
27776910	485	493	database	T170	C0242356
27776910	498	520	Durom acetabular shell	T074	C0025080
27776910	521	529	revision	T079	C0439617
27776910	546	552	months	T079	C0439231
27776910	557	563	months	T079	C0439231
27776910	569	574	years	T079	C0439234
27776910	576	585	follow-up	T058	C1522577
27776910	587	595	Patients	T101	C0030705
27776910	603	612	diagnosis	T033	C0011900
27776910	616	623	painful	T184	C0030193
27776910	624	635	micromotion	T070	C0026597
27776910	643	650	absence	T169	C0332197
27776910	654	665	pseudotumor	T020	C0033844
27776910	685	703	mid-term follow-up	T058	C1522577
27776910	708	716	patients	T101	C0030705
27776910	731	739	revision	T079	C0439617
27776910	745	755	Durom MOMA	T061	C0003893
27776910	794	801	painful	T184	C0030193
27776910	802	813	micromotion	T070	C0026597
27776910	817	839	total hip arthroplasty	T061	C0040508
27776910	844	859	hip resurfacing	T061	C1719285
27776910	868	871	cup	T074	C0180231
27776910	889	905	revision surgery	T061	C0035110
27776910	911	919	patients	T101	C0030705
27776910	920	928	reported	T058	C0700287
27776910	929	939	resolution	T077	C2699488
27776910	947	959	preoperative	T079	C0445204
27776910	960	964	pain	T184	C0030193
27776910	977	989	satisfactory	T080	C0205410
27776910	990	1006	outcome measures	T081	C0086749
27776910	1008	1019	mean scores	T033	C3533236
27776910	1025	1082	Western Ontario and McMaster Universities Arthritis Index	T170	C3472647
27776910	1084	1089	WOMAC	T170	C3472647
27776910	1097	1113	oxford hip score	T201	C1998079
27776910	1120	1144	Short Form Health Survey	T062	C0018762
27776910	1146	1151	SF-16	T062	C0018762
27776910	1157	1181	University of California	T073,T092	C0041740
27776910	1183	1194	Los Angeles	T083	C0024015
27776910	1196	1200	UCLA	T073,T092	C0041740
27776910	1208	1222	Radiologically	UnknownType	C0748230
27776910	1228	1233	cases	T169	C0868928
27776910	1247	1263	osseointegration	T042	C0079949
27776910	1271	1279	revision	T079	C0439617
27776910	1280	1286	shells	T080	C1948022
27776910	1290	1294	case	T169	C0868928
27776910	1299	1318	zone-3 radiolucency	T067	C2827491
27776910	1328	1342	nonprogressive	T033	C3839460
27776910	1348	1355	patient	T101	C0030705
27776910	1362	1373	dislocation	T037	C0012691
27776910	1374	1381	treated	T061	C0087111
27776910	1385	1401	closed reduction	T061	C0177475
27776910	1408	1413	weeks	T079	C0439230
27776910	1415	1423	Revision	T079	C0439617
27776910	1424	1428	MOMA	T061	C0003893
27776910	1433	1440	painful	T184	C0030193
27776910	1441	1452	micromotion	T070	C0026597
27776910	1460	1465	shell	T074	C0025080
27776910	1473	1480	absence	T169	C0332197
27776910	1484	1488	ALTR	T046	C3854631
27776910	1507	1515	revision	T079	C0439617
27776910	1520	1524	ALTR	T046	C3854631
27776910	1532	1547	associated with	T080	C0332281
27776910	1548	1559	predictable	T078	C0681842
27776910	1560	1571	improvement	T077	C2986411
27776910	1575	1579	pain	T184	C0030193
27776910	1584	1599	quality of life	T078	C0034380